Salazosulfapyridine treatment for patients with rheumatoid arthritis
| Autor: | Hiroshi Hagino, Noriaki Yamamoto, Ryota Teshima, Kichizo Yamamoto |
|---|---|
| Rok vydání: | 1998 |
| Předmět: |
musculoskeletal diseases
medicine.medical_specialty business.industry Disease duration fungi Morning stiffness medicine.disease Gastroenterology Surgery Grip strength Rheumatoid arthritis Internal medicine Medicine Rheumatoid factor Salazosulphapyridine Therapy duration skin and connective tissue diseases business |
| Zdroj: | Orthopedics & Traumatology. 47:345-349 |
| ISSN: | 1349-4333 0037-1033 |
| DOI: | 10.5035/nishiseisai.47.345 |
| Popis: | Twenty-seven patients with rheumatoid arthritis were evaluated for the effect of salazosulphapyridine (SASP) administration over a 5 month period. Twenty-two patients continued with administration of SASP but 5 patients failed. Lansbury's articular index was significantly improved and morning stiffness, grip strength, Lansbury's systemic index and CRP tended to improve. However ESR and rheumatoid factor did not change. The effect of SASP was independant of subsets of rheumatoid arthritis classified by Ochi, and disease duration, but associated with therapy duration and Lansbury's systemic index. In the SASP effective group, CRP was significantly high. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|